Ambu A/S (CO:AMBU-B) — Market Cap & Net Worth
Market Cap & Net Worth: Ambu A/S (AMBU-B)
Ambu A/S (CO:AMBU-B) has a market capitalization of $2.28 Billion (Dkr14.55 Billion) as of May 2, 2026. Listed on the CO stock exchange, this Denmark-based company holds position #5802 globally and #35 in its home market, demonstrating a -7.35% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ambu A/S's stock price Dkr63.05 by its total outstanding shares 230779231 (230.78 Million). Review Ambu A/S total liabilities to assess the company's total debt and financial obligations.
Ambu A/S Market Cap History: 2015 to 2026
Ambu A/S's market capitalization history from 2015 to 2026. Data shows growth from $1.49 Billion to $2.28 Billion (4.72% CAGR).
Ambu A/S Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ambu A/S's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.53x
Ambu A/S's market cap is 0.53 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.22x
Ambu A/S's market cap is 5.22 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.02 Billion | $2.08 Billion | $250.00 Million | 0.97x | 8.09x |
| 2017 | $3.98 Billion | $2.35 Billion | $301.00 Million | 1.69x | 13.22x |
| 2018 | $5.62 Billion | $2.61 Billion | $337.00 Million | 2.16x | 16.67x |
| 2019 | $4.02 Billion | $2.82 Billion | $317.00 Million | 1.43x | 12.68x |
| 2020 | $9.49 Billion | $3.57 Billion | $241.00 Million | 2.66x | 39.37x |
| 2021 | $6.25 Billion | $4.01 Billion | $247.00 Million | 1.56x | 25.29x |
| 2022 | $3.21 Billion | $4.44 Billion | $93.00 Million | 0.72x | 34.55x |
| 2023 | $3.80 Billion | $4.78 Billion | $168.00 Million | 0.80x | 22.61x |
| 2024 | $3.76 Billion | $5.39 Billion | $235.00 Million | 0.70x | 15.98x |
| 2025 | $3.18 Billion | $6.04 Billion | $609.00 Million | 0.53x | 5.22x |
Competitor Companies of AMBU-B by Market Capitalization
Companies near Ambu A/S in the global market cap rankings as of May 2, 2026.
Key companies related to Ambu A/S by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #140 globally with a market cap of $157.87 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #196 globally with a market cap of $120.60 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #234 globally with a market cap of $103.80 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #140 | Abbott Laboratories | NYSE:ABT | $157.87 Billion | $90.79 |
| #196 | Stryker Corporation | NYSE:SYK | $120.60 Billion | $315.13 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #234 | Medtronic PLC | NYSE:MDT | $103.80 Billion | $80.97 |
Ambu A/S Historical Marketcap From 2015 to 2026
Between 2015 and today, Ambu A/S's market cap moved from $1.49 Billion to $ 2.28 Billion, with a yearly change of 4.72%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Dkr2.28 Billion | -28.35% |
| 2025 | Dkr3.18 Billion | -15.38% |
| 2024 | Dkr3.76 Billion | -1.14% |
| 2023 | Dkr3.80 Billion | +18.20% |
| 2022 | Dkr3.21 Billion | -48.55% |
| 2021 | Dkr6.25 Billion | -34.16% |
| 2020 | Dkr9.49 Billion | +135.96% |
| 2019 | Dkr4.02 Billion | -28.42% |
| 2018 | Dkr5.62 Billion | +41.19% |
| 2017 | Dkr3.98 Billion | +96.82% |
| 2016 | Dkr2.02 Billion | +36.07% |
| 2015 | Dkr1.49 Billion | -- |
End of Day Market Cap According to Different Sources
On May 1st, 2026 the market cap of Ambu A/S was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.28 Billion USD |
| MoneyControl | $2.28 Billion USD |
| MarketWatch | $2.28 Billion USD |
| marketcap.company | $2.28 Billion USD |
| Reuters | $2.28 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ambu A/S
Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as… Read more